Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Ohio State University Comprehensive Cancer Center

Ohio State University Comprehensive Cancer Center in Columbus, Ohio, United States is listed as a site for 1,006 registered clinical trials, 556 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,006
Ongoing 556

This page covers the site record Ohio State University Comprehensive Cancer Center in Columbus, Ohio, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Ohio State University Comprehensive Cancer Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,006 trials counted.

  • Phase 1 174 trials
  • Phase 1/2 57 trials
  • Phase 2 340 trials
  • Phase 2/3 34 trials
  • Phase 3 197 trials
  • Phase 4 6 trials
  • Not applicable 155 trials
  • Observational 41 trials
  • Expanded access 1 trial
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 557 trials
  • Completed 339 trials
  • Terminated 89 trials
  • Other 21 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Unknown)

Top of scale: 79

1992: 1 trials (Observational 1) 1998: 2 trials (Observational 2) 1999: 1 trials (Phase 3 1) 2000: 4 trials (Phase 3 3, Phase 2 1) 2001: 1 trials (Phase 2 1) 2002: 1 trials (Observational 1) 2003: 2 trials (Phase 3 2) 2004: 4 trials (Phase 3 2, Phase 2 2) 2005: 10 trials (Phase 3 4, Phase 2 3, Phase 1/2 2, Phase 1 1) 2006: 6 trials (Phase 3 2, Phase 2 3, Phase 1 1) 2007: 10 trials (Other 1, Observational 1, Phase 3 4, Phase 2 3, Phase 1/2 1) 2008: 17 trials (Phase 3 7, Phase 2 6, Phase 1 4) 2009: 22 trials (Phase 3 13, Phase 2 4, Phase 1/2 2, Phase 1 3) 2010: 32 trials (Observational 2, Not applicable 2, Phase 3 7, Phase 2 12, Phase 1/2 3, Phase 1 6) 2011: 28 trials (Observational 2, Not applicable 2, Phase 4 1, Phase 3 6, Phase 2 12, Phase 1/2 1, Phase 1 4) 2012: 22 trials (Observational 1, Not applicable 1, Phase 3 4, Phase 2/3 1, Phase 2 11, Phase 1/2 2, Phase 1 2) 2013: 33 trials (Observational 2, Not applicable 3, Phase 3 4, Phase 2/3 2, Phase 2 11, Phase 1/2 1, Phase 1 10) 2014: 54 trials (Observational 3, Not applicable 2, Phase 3 9, Phase 2/3 10, Phase 2 18, Phase 1/2 3, Phase 1 9) 2015: 49 trials (Observational 1, Not applicable 8, Phase 3 11, Phase 2/3 1, Phase 2 20, Phase 1/2 3, Phase 1 5) 2016: 36 trials (Not applicable 8, Phase 3 4, Phase 2/3 1, Phase 2 12, Phase 1/2 1, Phase 1 10) 2017: 61 trials (Not applicable 8, Phase 3 12, Phase 2/3 2, Phase 2 30, Phase 1/2 2, Phase 1 7) 2018: 62 trials (Observational 1, Not applicable 8, Phase 3 11, Phase 2/3 1, Phase 2 25, Phase 1/2 5, Phase 1 11) 2019: 67 trials (Not applicable 7, Phase 3 16, Phase 2/3 4, Phase 2 21, Phase 1/2 4, Phase 1 15) 2020: 76 trials (Observational 6, Not applicable 14, Phase 3 11, Phase 2/3 1, Phase 2 23, Phase 1/2 5, Phase 1 16) 2021: 75 trials (Observational 6, Not applicable 16, Phase 3 12, Phase 2/3 4, Phase 2 16, Phase 1/2 2, Phase 1 19) 2022: 56 trials (Observational 4, Not applicable 13, Phase 3 5, Phase 2/3 4, Phase 2 16, Phase 1/2 2, Phase 1 12) 2023: 79 trials (Observational 3, Not applicable 15, Phase 4 1, Phase 3 11, Phase 2/3 1, Phase 2 31, Phase 1/2 4, Phase 1 13) 2024: 62 trials (Not applicable 17, Phase 3 7, Phase 2/3 1, Phase 2 22, Phase 1/2 4, Phase 1 11) 2025: 62 trials (Observational 2, Not applicable 11, Phase 4 2, Phase 3 21, Phase 2/3 1, Phase 2 13, Phase 1/2 5, Phase 1 7)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 68
2025 62
2024 62
2023 79
2022 56
2021 75
2020 76
2019 67
2018 62
2017 61

Showing 10 of 30 years.

Start your 14-day trial Email me all 30 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 2 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,006 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 47 lead sponsors.

Start your 14-day trial Email me all 47 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 278 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF